157 related articles for article (PubMed ID: 19995586)
21. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N.
Tatini F; Pugliese AM; Traini C; Niccoli S; Maraula G; Ed Dami T; Mannini B; Scartabelli T; Pedata F; Casamenti F; Chiti F
Neurobiol Aging; 2013 Sep; 34(9):2100-9. PubMed ID: 23601807
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats.
Han WN; Hölscher C; Yuan L; Yang W; Wang XH; Wu MN; Qi JS
Neurobiol Aging; 2013 Feb; 34(2):576-88. PubMed ID: 22592020
[TBL] [Abstract][Full Text] [Related]
23. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
24. [Brain-derived neurotrophic factor prevents against amyloid beta protein-induced impairment of hippocampal in vivo long-term potentiation in rats].
Li QS; Yang W; Pan YF; Min J; Zhang Z; Gao HZ; Qi JS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Sep; 28(5):425-9. PubMed ID: 23252296
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
26. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
27. Glucose directs amyloid-beta into membrane-active oligomers.
Kedia N; Almisry M; Bieschke J
Phys Chem Chem Phys; 2017 Jul; 19(27):18036-18046. PubMed ID: 28671211
[TBL] [Abstract][Full Text] [Related]
28. Self-assembly pathways of E22Δ-type amyloid β peptide mutants generated from non-aggregative O-acyl isopeptide precursors.
Sohma Y; Wang H; Taniguchi A; Hirayama Y; Kakizawa T; Yamasaki M; Mukai H; Kiso Y
Bioorg Med Chem; 2011 Jun; 19(12):3787-92. PubMed ID: 21612934
[TBL] [Abstract][Full Text] [Related]
29. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.
Petkova AT; Leapman RD; Guo Z; Yau WM; Mattson MP; Tycko R
Science; 2005 Jan; 307(5707):262-5. PubMed ID: 15653506
[TBL] [Abstract][Full Text] [Related]
30. Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo.
Szegedi V; Juhász G; Rózsa E; Juhász-Vedres G; Datki Z; Fülöp L; Bozsó Z; Lakatos A; Laczkó I; Farkas T; Kis Z; Tóth G; Soós K; Zarándi M; Budai D; Toldi J; Penke B
FASEB J; 2006 Jun; 20(8):1191-3. PubMed ID: 16636106
[TBL] [Abstract][Full Text] [Related]
31. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
[TBL] [Abstract][Full Text] [Related]
32. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
[TBL] [Abstract][Full Text] [Related]
33. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
34. A brief, but repeated, swimming protocol is sufficient to overcome amyloid beta-protein inhibition of hippocampal long-term potentiation.
Li S; Feig LA; Hartley DM
Eur J Neurosci; 2007 Sep; 26(5):1289-98. PubMed ID: 17767506
[TBL] [Abstract][Full Text] [Related]
35. A new class of aggregation inhibitor of amyloid-β peptide based on an O-acyl isopeptide.
Kawashima H; Sohma Y; Nakanishi T; Kitamura H; Mukai H; Yamashita M; Akaji K; Kiso Y
Bioorg Med Chem; 2013 Nov; 21(21):6323-7. PubMed ID: 24076366
[TBL] [Abstract][Full Text] [Related]
36. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
37. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
38. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.
Klyubin I; Walsh DM; Cullen WK; Fadeeva JV; Anwyl R; Selkoe DJ; Rowan MJ
Eur J Neurosci; 2004 May; 19(10):2839-46. PubMed ID: 15147317
[TBL] [Abstract][Full Text] [Related]
39. Lack of support for bexarotene as a treatment for Alzheimer's disease.
O'Hare E; Jeggo R; Kim EM; Barbour B; Walczak JS; Palmer P; Lyons T; Page D; Hanna D; Meara JR; Spanswick D; Guo JP; McGeer EG; McGeer PL; Hobson P
Neuropharmacology; 2016 Jan; 100():124-30. PubMed ID: 26025659
[TBL] [Abstract][Full Text] [Related]
40. Structure and dynamics of small soluble Aβ(1-40) oligomers studied by top-down hydrogen exchange mass spectrometry.
Pan J; Han J; Borchers CH; Konermann L
Biochemistry; 2012 May; 51(17):3694-703. PubMed ID: 22486153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
